Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading

Latest News

Integra LifeSciences Announces Key Executive Leadership Appointments
globenewswire.com

Integra LifeSciences Announces Key Executive Leadership Appointments

PRINCETON, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Teshtar Elavia as corporate vice president and chief technology officer, a newly created position to lead research and development (R&D), including product and technology development, across the company.

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026
globenewswire.com

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026

PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET.

168,000 Shares in Integra LifeSciences Holdings Corporation $IART Purchased by Hussman Strategic Advisors Inc.
defenseworld.net

168,000 Shares in Integra LifeSciences Holdings Corporation $IART Purchased by Hussman Strategic Advisors Inc.

Hussman Strategic Advisors Inc. purchased a new stake in shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 168,000 shares of the life sciences company's stock, valued at approximately $2,407,000. Hussman Strategic Advisors Inc. owned

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference

PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m ET or 11:15 a.m PT

Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
globenewswire.com

Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference

PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m ET A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.